Feasibility study of carboplatin plus TS-1 combination chemotherapy for completely resected non-small cell lung cancer (ALCSG-1001)

Trial Profile

Feasibility study of carboplatin plus TS-1 combination chemotherapy for completely resected non-small cell lung cancer (ALCSG-1001)

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 13 May 2016

At a glance

  • Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top